Labcorp launches new test to identify and confirm neurodegenerative disease
Test Measures Key Biomarker Associated with Neuronal Damage; Assists in Diagnosis of Diseases Including Multiple Sclerosis, Alzheimer’s, Parkinson’s and Concussions
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220713005453/en/
“NfL is a simple, objective blood test that provides direct evidence of neuronal damage,” said Dr.
Neurological disease presents in many forms, and today, confirmation of disease is often complex and challenging. When neurons are damaged, proteins called neurofilaments are released and are detectable in blood. One of three main neurofilament types, NfL has been the most widely studied in research settings, but a reliable NfL test has not been widely available for patient care. Broad availability to physicians as part of their diagnostic toolbox is expected to provide significant benefits in supporting more effective diagnosis and treatment of many disorders.
“Importantly, NfL isn’t specific to one disease, but it is highly specific to neuronal damage from a wide variety of causes, from Alzheimer’s and multiple sclerosis to concussion and physical injury. This test will be impactful in helping many patients,” said Dr.
The new NfL test is performed from a standard blood collection that can be done at a hospital, physician’s office or at any of Labcorp’s nearly 2,000 patient service centers. Launch and availability of the test demonstrates Labcorp’s commitment to neurology and to improving the health and lives of the millions afflicted by neurodegenerative and related diseases.
Health care providers will be able to order the test beginning today. More information on the NfL test is available at www.labcorp.com/nfl.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, including but not limited to statements with respect to the clinical utility and expected performance of its Neurofilament Light Chain test.
The company has no obligation to provide any updates to forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the company’s most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in the company’s other filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005453/en/